constructed a nanodrug delivery system (HA-LSL/siTGF-β) designed for the effective transport of siRNA aimed at TGF-β to simultaneously silence TGF-β in stromal and cancer cells, reducing stromal cell deposition and promoting nanoparticle penetration. This evidence concerns the gene TGFB1 and cancer.